Dermata Therapeutics Inc (DRMA) Stock Price, Quote, News & History

DRMANASDAQ
$1.32
At close: Jul 15, 5:00 PM EST
$1.33
0.010.76%
After Hours: 7:34 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-8.30M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
5.53M
Free Cash Flow (TTM)
-8.30M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-2.77M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$1.64M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.83
Earnings Yield % (TTM)
-315.91%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.59

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$6.95M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 74.32K
Day Range
- - -
52 Wk Range
1.10 - 8.00
Market Cap
$5.35M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
4.17%
Days to Cover
1.23

About

Sector
Health Care
Industry
Biotechnology
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, r...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Dermata Therapeutics (DRMA) stock?

A

You can purchase shares of Dermata Therapeutics (NASDAQ:DRMA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Dermata Therapeutics (DRMA) competitors?

A

There are no as such competitors for Dermata Therapeutics.

Q

What is the forecast, or price target, for Dermata Therapeutics (DRMA) stock?

A

Dermata Therapeutics has a consensus price target of $10.00.

Q

What is the current price for Dermata Therapeutics (DRMA)?

A

The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $1.33 last updated July 14, 2026 at 7:34 PM EDT.

Q

Does Dermata Therapeutics (DRMA) pay a dividend?

A

There are no upcoming dividends for Dermata Therapeutics.

Q

When is Dermata Therapeutics (NASDAQ:DRMA) reporting earnings?

A

Dermata Therapeutics does not have any upcoming earnings scheduled.

Q

Is Dermata Therapeutics (DRMA) going to split?

A

There is no upcoming split for Dermata Therapeutics.

Q

What sector and industry does Dermata Therapeutics (DRMA) operate in?

A

Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.